{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:24:30Z","timestamp":1778034270249,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09293-0","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:19:46Z","timestamp":1764940786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopes"],"prefix":"10.1038","volume":"9","author":[{"given":"Shihao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-8074","authenticated-orcid":false,"given":"Chao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunting","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6805-7263","authenticated-orcid":false,"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-6449","authenticated-orcid":false,"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"9293_CR1","doi-asserted-by":"publisher","first-page":"108701","DOI":"10.1016\/j.abb.2020.108701","volume":"697","author":"ECA Eleutherio","year":"2021","unstructured":"Eleutherio, E. C. A. et al. SOD1, more than just an antioxidant. Arch. Biochem. Biophys. 697, 108701 (2021).","journal-title":"Arch. Biochem. Biophys."},{"key":"9293_CR2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jmb.2005.11.081","volume":"356","author":"RW Strange","year":"2006","unstructured":"Strange, R. W. et al. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu\u2013Zn, Zn\u2013Zn and As-isolated wild-type enzymes. J. Mol. Biol. 356, 1152\u20131162 (2006).","journal-title":"J. Mol. Biol."},{"key":"9293_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2011.3999","volume":"15","author":"T Fukai","year":"2011","unstructured":"Fukai, T. & Ushio-Fukai, M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signal 15, 1583\u20131606 (2011).","journal-title":"Antioxid. Redox Signal"},{"key":"9293_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1083\/jcb.201708007","volume":"217","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J. Cell Biol. 217, 1915\u20131928 (2018).","journal-title":"J. Cell Biol."},{"key":"9293_CR5","doi-asserted-by":"crossref","unstructured":"Montllor-Albalate, C. et al. Sod1 integrates oxygen availability to redox regulate NADPH production and the thiol redoxome. Proc. Natl. Acad. Sci. USA 119, e2023328119 (2022).","DOI":"10.1073\/pnas.2023328119"},{"key":"9293_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"9293_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jbior.2015.10.006","volume":"60","author":"Y Hayashi","year":"2016","unstructured":"Hayashi, Y., Homma, K. & Ichijo, H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv. Biol. Regul. 60, 95\u2013104 (2016).","journal-title":"Adv. Biol. Regul."},{"key":"9293_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-016-0050-8","volume":"5","author":"HF Li","year":"2016","unstructured":"Li, H. F. & Wu, Z. Y. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl. Neurodegener. 5, 3 (2016).","journal-title":"Transl. Neurodegener."},{"key":"9293_CR9","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"9293_CR10","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","volume":"93","author":"PH Tu","year":"1996","unstructured":"Tu, P. H. et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA 93, 3155\u20133160 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9293_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"PC Wong","year":"1995","unstructured":"Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105\u20131116 (1995).","journal-title":"Neuron"},{"key":"9293_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fncel.2013.00253","volume":"7","author":"MS Rotunno","year":"2013","unstructured":"Rotunno, M. S. & Bosco, D. A. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell Neurosci. 7, 253 (2013).","journal-title":"Front. Cell Neurosci."},{"key":"9293_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31773-z","volume":"8","author":"B Pare","year":"2018","unstructured":"Pare, B. et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 8, 14223 (2018).","journal-title":"Sci. Rep."},{"key":"9293_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/21678707.2020.1835638","volume":"8","author":"JP Franklin","year":"2020","unstructured":"Franklin, J. P., Azzouz, M. & Shaw, P. J. SOD1-targeting therapies for neurodegenerative diseases: a review of current findings and future potential. Expert Opin. Orphan Drugs 8, 379\u2013392 (2020).","journal-title":"Expert Opin. Orphan Drugs"},{"key":"9293_CR15","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/JCI25424","volume":"116","author":"RA Smith","year":"2006","unstructured":"Smith, R. A. et al. Antisense oligonucleotide therapy for neurodegenerative disease. J. Clin. Invest. 116, 2290\u20132296 (2006).","journal-title":"J. Clin. Invest."},{"key":"9293_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","volume":"2","author":"H Ding","year":"2003","unstructured":"Ding, H. et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209\u2013217 (2003).","journal-title":"Aging Cell"},{"key":"9293_CR17","doi-asserted-by":"publisher","first-page":"eaar3952","DOI":"10.1126\/sciadv.aar3952","volume":"3","author":"T Gaj","year":"2017","unstructured":"Gaj, T. et al. In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci. Adv. 3, eaar3952 (2017).","journal-title":"Sci. Adv."},{"key":"9293_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2020.1738390","volume":"24","author":"E Abati","year":"2020","unstructured":"Abati, E. et al. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS). Expert Opin. Ther. Targets 24, 295\u2013310 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"key":"9293_CR19","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1212\/WNL.0000000000004960","volume":"90","author":"M Benatar","year":"2018","unstructured":"Benatar, M. et al. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology 90, e565\u2013e574 (2018).","journal-title":"Neurology"},{"key":"9293_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05127-2","volume":"9","author":"N Tsuburaya","year":"2018","unstructured":"Tsuburaya, N. et al. A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model. Nat. Commun. 9, 2668 (2018).","journal-title":"Nat. Commun."},{"key":"9293_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/17482968.2012.724074","volume":"14","author":"DJ Lange","year":"2013","unstructured":"Lange, D. J. et al. Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 199\u2013204 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"9293_CR22","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/acschemneuro.6b00227","volume":"7","author":"V Banerjee","year":"2016","unstructured":"Banerjee, V. et al. Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem. Neurosci. 7, 1595\u20131606 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"9293_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fncel.2019.00346","volume":"13","author":"A Shteinfer-Kuzmine","year":"2019","unstructured":"Shteinfer-Kuzmine, A. et al. A VDAC1-derived N-terminal peptide inhibits mutant SOD1-VDAC1 interactions and toxicity in the SOD1 model of ALS. Front. Cell Neurosci. 13, 346 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"9293_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","volume":"113","author":"F Gros-Louis","year":"2010","unstructured":"Gros-Louis, F. et al. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 113, 1188\u20131199 (2010).","journal-title":"J. Neurochem."},{"key":"9293_CR25","doi-asserted-by":"publisher","first-page":"eaah3924","DOI":"10.1126\/scitranslmed.aah3924","volume":"10","author":"M Maier","year":"2018","unstructured":"Maier, M. et al. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci. Transl. Med. 10, eaah3924 (2018).","journal-title":"Sci. Transl. Med."},{"key":"9293_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1073\/pnas.0606201104","volume":"104","author":"M Urushitani","year":"2007","unstructured":"Urushitani, M., Ezzi, S. A. & Julien, J. P. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 104, 2495\u20132500 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9293_CR27","doi-asserted-by":"crossref","unstructured":"Jin, B. K. et al., NANOBODIES(R): a review of diagnostic and therapeutic applications. Int. J. Mol. Sci. 24, 5994 (2023).","DOI":"10.3390\/ijms24065994"},{"key":"9293_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446\u2013448 (1993).","journal-title":"Nature"},{"key":"9293_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0161-5890(94)90001-9","volume":"31","author":"EA Padlan","year":"1994","unstructured":"Padlan, E. A. Anatomy of the antibody molecule. Mol. Immunol. 31, 169\u2013217 (1994).","journal-title":"Mol. Immunol."},{"key":"9293_CR30","doi-asserted-by":"crossref","unstructured":"Zhu, H. & Ding, Y. Nanobodies: from discovery to AI-driven design. Biology 14, 547 (2025).","DOI":"10.3390\/biology14050547"},{"key":"9293_CR31","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","volume":"8","author":"P Bannas","year":"2017","unstructured":"Bannas, P., Hambach, J. & Koch-Nolte, F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front. Immunol. 8, 1603 (2017).","journal-title":"Front. Immunol."},{"key":"9293_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26338-z","volume":"8","author":"P Kunz","year":"2018","unstructured":"Kunz, P. et al. The structural basis of nanobody unfolding reversibility and thermoresistance. Sci. Rep. 8, 7934 (2018).","journal-title":"Sci. Rep."},{"key":"9293_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s43141-022-00439-9","volume":"20","author":"TTT Truong","year":"2022","unstructured":"Truong, T. T. T. et al. Studying the characteristics of nanobody CDR regions based on sequence analysis in combination with 3D structures. J. Genet. Eng. Biotechnol. 20, 157 (2022).","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"9293_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-1-0716-2075-5_14","volume":"2446","author":"T Sulea","year":"2022","unstructured":"Sulea, T. Humanization of camelid single-domain antibodies. Methods Mol. Biol. 2446, 299\u2013312 (2022).","journal-title":"Methods Mol. Biol."},{"key":"9293_CR35","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2147\/IJN.S297631","volume":"16","author":"S Sun","year":"2021","unstructured":"Sun, S. et al. Nanobody: a small antibody with big implications for tumor therapeutic strategy. Int. J. Nanomed. 16, 2337\u20132356 (2021).","journal-title":"Int. J. Nanomed."},{"key":"9293_CR36","unstructured":"Robberecht, W., Rousseau, F. & Schymkowitz, J. Single Domain Antibodies Against SOD1 and Their Use in Medicine (V.I.v.B.V. Katholieke Universiteit Leuven, Life Sciences Research Partners vzw, Editor, 2014)."},{"key":"9293_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2013.03.034","volume":"153","author":"R Nussinov","year":"2013","unstructured":"Nussinov, R. & Tsai, C. J. Allostery in disease and in drug discovery. Cell 153, 293\u2013305 (2013).","journal-title":"Cell"},{"key":"9293_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1039\/b819720b","volume":"5","author":"CJ Tsai","year":"2009","unstructured":"Tsai, C. J., Del Sol, A. & Nussinov, R. Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol. Biosyst. 5, 207\u2013216 (2009).","journal-title":"Mol. Biosyst."},{"key":"9293_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.expneurol.2019.05.008","volume":"318","author":"LR Hayes","year":"2019","unstructured":"Hayes, L. R. et al. Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminal. Exp. Neurol. 318, 251\u2013257 (2019).","journal-title":"Exp. Neurol."},{"key":"9293_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.expneurol.2011.09.020","volume":"233","author":"LR Fischer","year":"2012","unstructured":"Fischer, L. R. et al. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp. Neurol. 233, 163\u2013171 (2012).","journal-title":"Exp. Neurol."},{"key":"9293_CR41","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1073\/pnas.0730423100","volume":"100","author":"JS Valentine","year":"2003","unstructured":"Valentine, J. S. & Hart, P. J. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 100, 3617\u20133622 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9293_CR42","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s42003-022-04017-0","volume":"5","author":"Y Baek","year":"2022","unstructured":"Baek, Y. et al. Structural analysis of the overoxidized Cu\/Zn-superoxide dismutase in ROS-induced ALS filament formation. Commun. Biol. 5, 1085 (2022).","journal-title":"Commun. Biol."},{"key":"9293_CR43","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. L. & Shen, W. C. Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9293_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/10904","volume":"17","author":"GS Waldo","year":"1999","unstructured":"Waldo, G. S. et al. Rapid protein-folding assay using green fluorescent protein. Nat. Biotechnol. 17, 691\u2013695 (1999).","journal-title":"Nat. Biotechnol."},{"key":"9293_CR45","unstructured":"Georg Bauer, M. M. Antigen-binding constructs, namely single domain vhh fragments which bind to and inhibit catalase and\/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy, U. Freiburg, Editor. (2016)."},{"key":"9293_CR46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"9293_CR47","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1074\/jbc.M313295200","volume":"279","author":"R Rakhit","year":"2004","unstructured":"Rakhit, R. et al. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279, 15499\u201315504 (2004).","journal-title":"J. Biol. Chem."},{"key":"9293_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01996-1","volume":"8","author":"S Sen Mojumdar","year":"2017","unstructured":"Sen Mojumdar, S. et al. Partially native intermediates mediate misfolding of SOD1 in single-molecule folding trajectories. Nat. Commun. 8, 1881 (2017).","journal-title":"Nat. Commun."},{"key":"9293_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31240-4","volume":"13","author":"LQ Wang","year":"2022","unstructured":"Wang, L. Q. et al. Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion. Nat. Commun. 13, 3491 (2022).","journal-title":"Nat. Commun."},{"key":"9293_CR50","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1074\/jbc.M115.683763","volume":"291","author":"Y Furukawa","year":"2016","unstructured":"Furukawa, Y. et al. Conformational disorder of the most immature Cu, Zn-superoxide dismutase leading to amyotrophic lateral sclerosis. J. Biol. Chem. 291, 4144\u20134155 (2016).","journal-title":"J. Biol. Chem."},{"key":"9293_CR51","doi-asserted-by":"publisher","first-page":"27598","DOI":"10.1039\/D0RA02151B","volume":"10","author":"I Jahan","year":"2020","unstructured":"Jahan, I. & Nayeem, S. M. Conformational dynamics of superoxide dismutase (SOD1) in osmolytes: a molecular dynamics simulation study. RSC Adv. 10, 27598\u201327614 (2020).","journal-title":"RSC Adv."},{"key":"9293_CR52","doi-asserted-by":"crossref","unstructured":"Kumar, M. S. et al. Anti-SOD1 nanobodies that stabilize misfolded SOD1 proteins also promote neurite outgrowth in mutant SOD1 human neurons. Int. J. Mol. Sci. 23, 16013 (2022).","DOI":"10.3390\/ijms232416013"},{"key":"9293_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s41365-023-01350-9","volume":"34","author":"Q Xu","year":"2023","unstructured":"Xu, Q. et al. The biosafety level-2 macromolecular crystallography beamline (BL10U2) at the Shanghai Synchrotron Radiation Facility. Nucl. Sci. Tech. 34, 202 (2023).","journal-title":"Nucl. Sci. Tech."},{"key":"9293_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"9293_CR55","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"N Collaborative Computational Project","year":"1994","unstructured":"Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9293_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P. et al. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9293_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9293_CR58","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1107\/S0907444904023510","volume":"60","author":"AA Vagin","year":"2004","unstructured":"Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D Biol. Crystallogr. 60, 2184\u20132195 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09293-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:04:30Z","timestamp":1767801870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09293-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9293"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09293-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}